ArticleSkeletal radiology2026
Incremental diagnostic value of multiregional single-slice CT muscle areas over L3 for sarcopenia: a deep learning-based segmentation study.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo compare the diagnostic performance of multiregional CT-based muscle assessment with conventional single-level (L3) evaluation. MATERIALS AND
methodsThis retrospective study included 83 adults who underwent multiregional non-contrast CT and completed sarcopenia assessments based on the Asian Working Group for Sarcopenia (AWGS) 2019 criteria. Skeletal muscle areas at six anatomical levels (T4, L3, ASIS, femoral head, midthigh, and proximal calf) were automatically quantified using a deep learning-based segmentation software (DeepCatch). The diagnostic performance of single-slice muscle areas was evaluated using the area under the receiver operating characteristic curve (AUC). Pearson's or Spearman's correlation coefficients were analyzed to assess the relationship between CT-derived muscle metrics and functional status.
resultsMultiregional muscle assessment demonstrated the highest diagnostic performance. In a clinical prediction model, models incorporating three-site and six-site muscle areas improved discrimination compared with the clinical base model (ΔAUC 0.123 and 0.136, respectively), and these improvements remained significant after BH-FDR adjustment (both q = 0.034). In contrast, the addition of the midthigh muscle area showed a modest improvement (ΔAUC 0.089; p = 0.029), which did not remain significant after FDR adjustment (q = 0.064), and L3 muscle area provided limited incremental value.
conclusionMultiregional CT-based muscle assessment provides improved diagnostic performance for sarcopenia compared with single-level evaluation. Lower-extremity muscle measurements, particularly at the midthigh, contribute to this improvement, whereas reliance on L3 alone may be insufficient.
Indexed as
Identifiers
42095933What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.